inproquone (E39)

07/01/1957 - "[Action of E39 in malignant pharyngolaryngeal tumors]."
01/01/1960 - "[Electron microscopic studies on the effect of ethyleneiminoquinone (E39) and carcinophilin on ascites tumor cells. "
01/01/1999 - "An aqueous extract of the marine diatom Haslea ostrearia (Simonsen) was studied for its antiproliferative properties against human solid tumors: lung carcinoma (NSCLC-N6), kidney carcinoma (E39) and melanoma (M96). "
01/01/1999 - "Antitumor and antiproliferative effects of an aqueous extract from the marine diatom Haslea ostrearia (Simonsen) against solid tumors: lung carcinoma (NSCLC-N6), kidney carcinoma (E39) and melanoma (M96) cell lines."
12/01/1999 - "Both immunodominant E39 (FBP, 191-199) and subdominant E41 (FBP, 245-253) epitopes are presented by HLA-A2 in these cancers. "

01/01/1960 - "[Electron microscopic studies on the effect of ethyleneiminoquinone (E39) and carcinophilin on ascites tumor cells. "

03/15/2012 - "BGB formation proceeded through the complex processes of secarecytosis and peremerecytosis, which entailed decapitation of epithelial cells by cutting or pinching off respectively and by E39, the BGB was thin at 2.21 ± 1.21 μm. "

03/01/2010 - "At the end of the first trimester at E39 (39 days after gestation), neurofilament labeled ganglion cells, recoverin labeled photoreceptors, vimentin labeled Müller cells and synaptophysin labeled presynaptic vesicles were found. "

04/01/2015 - "Causes of death were tuberculosis (E02, 0.2%), lung malignancy (E15, 3.5%), influenza (E38, 0.2%), pneumonia (E39, 6.5%) and chronic lower respiratory diseases (E40, 3.2%). "